DNMT3A mutations and prognostic significance in childhood acute lymphoblastic leukemia

References

• Melki JR, Clark SJ. DNA methylation changes in leukaemia. Semin Cancer Biol 2002;12(5):347–57.
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation and chromatin - unraveling the tangled web. Oncogene 2002;21:5361–5379.
   PubMed Web of Science ®Google Scholar
• Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998;19:219–220.
   PubMed Web of Science ®Google Scholar
• Hsieh CL. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b. Mol Cell Biol 1999;19:8211–8218.
   PubMed Web of Science ®Google Scholar
• Xie S, Wang Z, Okano M, et al. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 1999;236:87–95.
   PubMed Web of Science ®Google Scholar
• Robertson KD, Uzvolgyi E, Liang G, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999;27:2291–2298.
   PubMed Web of Science ®Google Scholar
• Aryee MJ, Liu W, Engelmann JC, et al. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med 2013;5:169ra10.
   Google Scholar
• Aran D, Sabato S, Hellman A. DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes. Genome Biol 2013;14:R21.
   PubMed Web of Science ®Google Scholar
• Ostronoff F, Othus M, Ho PA, et al. Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report. Leukemia 2013;27: 238–241.
   PubMed Web of Science ®Google Scholar
• Shiba N, Taki T, Park MJ, et al. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia. Br J Haematol 2012;156: 413–414.
   PubMed Web of Science ®Google Scholar
• Hollink IH, Feng Q, Danen-van Oorschot AA, et al. Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model. Leukemia 2012;26: 371–373.
   PubMed Web of Science ®Google Scholar
• Thol F, Heuser M, Damm F, et al. DNMT3A mutations are rare in childhood acute myeloid leukemia. Haematologica 2011;96: 1238–1240.
   PubMed Web of Science ®Google Scholar
• Thol F, Damm F, Ludeking A, et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol 2011;29:2889–2896.
   PubMed Web of Science ®Google Scholar
• Lin J, Yao DM, Qian J, et al. Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS One 2011;6:e26906.
   PubMed Web of Science ®Google Scholar
• Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010;363:2424–2433.
   PubMed Web of Science ®Google Scholar
• Hou HA, Kuo YY, Liu CY, et al. DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood 2012;119:559–568.
   PubMed Web of Science ®Google Scholar
• Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 2011;43:309–315.
   PubMed Web of Science ®Google Scholar
• Shen Y, Zhu YM, Fan X, et al. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood 2011;118:5593–5603.
   PubMed Web of Science ®Google Scholar
• Markova J, Michkova P, Burckova K, et al. Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia. Eur J Haematol 2011;88:128–135.
   PubMed Web of Science ®Google Scholar
• Ho PA, Kutny MA, Alonzo TA, et al. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group. Pediatr Blood Cancer 2011;57:204–209.
   PubMed Web of Science ®Google Scholar
• Chen YM, Lu QY. [DNMT3A gene mutations in acute myeloid leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011;19:1556–1560.
   PubMedGoogle Scholar
• Szczepanski T, van der Velden VH, Hoogeveen PG, et al. Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells. Blood 2004;103:3798–3804.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257–2317.
   PubMed Web of Science ®Google Scholar
• van der Velden VH, van Dongen JJ. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR. Methods Mol Biol 2009;538: 115–150.
   PubMedGoogle Scholar
• Cui L, Li Z, Wu M, et al. Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia. Leuk Res 2010; 34:1314–1319.
   PubMed Web of Science ®Google Scholar
• Estey EH. Acute myeloid leukemia: 2013 update on risk-stratification and management. Am J Hematol 2013;88:318–327.
   PubMed Web of Science ®Google Scholar
• Wakita S, Yamaguchi H, Omori I, et al. Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia. Leukemia 2012;27:1044–1052.
   PubMed Web of Science ®Google Scholar
• Dombret H. Gene mutation and AML pathogenesis. Blood 2011;118:5366–5367.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Yuan J, Suetake I, et al. Array-based genomic resequencing of human leukemia. Oncogene 2010;29:3723–3731.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim YR, Yoo NJ, et al. Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers. APMIS 2013;121:85–94.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Metzeler KH, Schwind S, et al. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J Clin Oncol 2012;30:742–750.
   PubMed Web of Science ®Google Scholar
• Gaidzik VI, Schlenk RF, Paschka P, et al. Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). Blood 2013;121:4769–4777.
   PubMed Web of Science ®Google Scholar
• Lu Q, Chen Y, Wang H, et al. DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia. Cancer Cell Int 2013;13:1.
   PubMed Web of Science ®Google Scholar
• Ribeiro AF, Pratcorona M, Erpelinck-Verschueren C, et al. Mutant DNMT3A: a new marker of poor prognosis in acute myeloid leukemia. Blood 2012;119:5824–5831.
   PubMed Web of Science ®Google Scholar
• Entesarian M, Chiang SC, Schlums H, et al. Novel deep intronic and missense UNC13D mutations in familial haemophagocytic lymphohistiocytosis type 3. Br J Haematol 2013;162: 415–418.
   PubMed Web of Science ®Google Scholar
• Yu Q, Shen XH, Li Y, et al. An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia. PLoS One 2013;8:e58031
   Google Scholar